CV - CapsoVision, Inc. Common Stock

https://capsovision.com

Momentum: Bearish

Recent News

Bullish

CapsoVision Revenue Jumps 17 Percent

Motley Fool • 1 month ago • score: 0.28

CapsoVision ( NASDAQ:CV ) , a medical technology company focused on capsule endoscopy systems, released its second quarter 2025 results on August 14, 2025. The company posted a 17% rise in revenue ( GAAP ) to $3.3 million, slightly beating analyst expectations, as revenue ( GAAP ) of $3.3 million ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company is headquartered in Saratoga, California.

52W High

$5.72

52W Low

$3.49

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

N/A

Valuation

Source: Overview

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

N/A

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

N/A

Ownership

Source: Overview

Insiders (1–5% typical)

0.00%

Institutions (25–75% balanced)

0.00%

Shares Outstanding

Float

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Source: Overview

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

N/A

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

N/A

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

-0.1084

-0.1659

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025